Home LiteratureArticle Details
PMID: 34309564 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.

Journal of medical Internet research ·Vol. 23 ·No. 7 ·2021-00-26 ·Pages e27633

Lánczky A, Győrffy B

Abstract

Survival analysis is a cornerstone of medical research, enabling the assessment of clinical outcomes for disease progression and treatment efficiency. Despite its central importance, no commonly used spreadsheet software can handle survival analysis and there is no web server available for its computation. Here, we introduce a web-based tool capable of performing univariate and multivariate Cox proportional hazards survival analysis using data generated by genomic, transcriptomic, proteomic, or metabolomic studies. We implemented different methods to establish cut-off values for the trichotomization or dichotomization of continuous data. The false discovery rate is computed to correct for multiple hypothesis testing. A multivariate analysis option enables comparing omics data with clinical variables. We established a registration-free web-based survival analysis tool capable of performing univariate and multivariate survival analysis using any custom-generated data. This tool fills a gap and will be an invaluable contribution to basic medical and clinical research.

Keywords
Cox regression Kaplan-Meier plot follow-up internet multivariate analysis survival
MeSH Terms
Biomedical Research Humans Internet Proteomics Software Survival Analysis
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lánczky András ORCID
Department of Bioinformatics, Semmelweis University, Budapest, Hungary. | TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Győrffy Balázs ORCID
Department of Bioinformatics, Semmelweis University, Budapest, Hungary. | TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
References (16)
16 references, click to expand
  1. Statistical aspects of the analysis of data from retrospective studies of disease.
    J Natl Cancer Inst. 1959 Apr;22(4):719-48 PMID: 13655060
  2. A generalized two-sample Wilcoxon test for doubly censored data.
    Biometrika. 1965 Dec;52(3):650-3 PMID: 5858975
  3. Distinct prognostic values of mRNA expression of glutathione peroxidases in non-small cell lung cancer.
    Cancer Manag Res. 2018 Aug 28;10:2997-3005 PMID: 30214294
  4. Do optimal prognostic thresholds in continuous physiological variables really exist? Analysis of origin of apparent thresholds, with systematic review for peak oxygen consumption, ejection fraction and BNP.
    PLoS One. 2014 Jan 27;9(1):e81699 PMID: 24475020
  5. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression.
    Stat Med. 1995 Aug 15;14(15):1707-23 PMID: 7481205
  6. Comprehensive molecular portraits of human breast tumours.
    Nature. 2012 Oct 4;490(7418):61-70 PMID: 23000897
  7. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization.
    PLoS One. 2012;7(12):e51862 PMID: 23251644
  8. A snapshot of 3649 Web-based services published between 1994 and 2017 shows a decrease in availability after 2 years.
    Brief Bioinform. 2019 May 21;20(3):1004-1010 PMID: 29228189
  9. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
    Endocr Relat Cancer. 2012 Apr 10;19(2):197-208 PMID: 22277193
  10. Sample Size Estimation in Clinical Research: From Randomized Controlled Trials to Observational Studies.
    Chest. 2020 Jul;158(1S):S12-S20 PMID: 32658647
  11. A practical guide to understanding Kaplan-Meier curves.
    Otolaryngol Head Neck Surg. 2010 Sep;143(3):331-6 PMID: 20723767
  12. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
    Lancet. 2009 May 2;373(9674):1525-31 PMID: 19410716
  13. A Survey of Bioinformatics Database and Software Usage through Mining the Literature.
    PLoS One. 2016 Jun 22;11(6):e0157989 PMID: 27331905
  14. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.
    Breast Cancer Res Treat. 2016 Dec;160(3):439-446 PMID: 27744485
  15. A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study.
    J Med Internet Res. 2020 May 5;22(5):e16084 PMID: 32369034
  16. Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma.
    Front Genet. 2019 Jul 18;10:624 PMID: 31379917
Article Info
Journal
Journal of medical Internet research
Abbr.
J Med Internet Res
ISSN
1438-8871
Published
2021-00-26
Epub
2021-00-26
Pages
e27633
Language
English
Region
Canada
NLM ID
100959882
PMCID
PMC8367126
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com